000			01370 a2200373 4500
005			20250512040530.0
264		0	_c19881123
008			198811s 0 0 eng d
022			_a0162-3257
024	7		_a10.1007/BF02212198 _2doi
040			_aNLM _beng _cNLM
100	1		_aMartineau, J
245	0	0	_aBrief report: an open middle-term study of combined vitamin B6-magnesium in a subgroup of autistic children selected on their sensitivity to this treatment. _h[electronic resource]
260			_bJournal of autism and developmental disorders _cSep 1988
300			_a435-47 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAutistic Disorder _xdrug therapy
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aDopamine _xurine
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEvoked Potentials, Auditory _xdrug effects
650	0	4	_aFemale
650	0	4	_aHomovanillic Acid _xurine
650	0	4	_aHumans
650	0	4	_aMagnesium _xtherapeutic use
650	0	4	_aMale
650	0	4	_aPyridoxine _xtherapeutic use
700	1		_aBarthelemy, C
700	1		_aCheliakine, C
700	1		_aLelord, G
773	0		_tJournal of autism and developmental disorders _gvol. 18 _gno. 3 _gp. 435-47
856	4	0	_uhttps://doi.org/10.1007/BF02212198 _zAvailable from publisher's website
999			_c3176246 _d3176246